Orally Active Epoxyeicosatrienoic Acid Analog Attenuates Kidney Injury in Hypertensive Dahl Salt–Sensitive Rat

No abstract is available for this paper.

• Publication year

  2013

• Venue

  HYPERTENSION

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.113.01949PMID 23980070PMCID PMC3872985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity

  2013cited by this paper
• Epoxyeicosatrienoic Acids (EETs) Regulate Epithelial Sodium Channel Activity by Extracellular Signal-regulated Kinase 1/2 (ERK1/2)-mediated Phosphorylation*

  2013cited by this paper
• Endoplasmic Reticulum Stress Is Involved in Cardiac Damage and Vascular Endothelial Dysfunction in Hypertensive Mice

  2012cited by this paper
• Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

  2012cited by this paper
• Attenuation of Cisplatin-Induced Renal Injury by Inhibition of Soluble Epoxide Hydrolase Involves Nuclear Factor κB Signaling

  2012cited by this paper
• Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 Pathway

  2012cited by this paper
• Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension.

  2012cited by this paper
• Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib

  2012cited by this paper
• Cyp2c44 Epoxygenase Is Essential for Preventing the Renal Sodium Absorption During Increasing Dietary Potassium Intake

  2012cited by this paper
• The role of the kidney in regulating arterial blood pressure

  2012cited by this paper
• Mechanisms and consequences of salt sensitivity and dietary salt intake

  2011cited by this paper
• Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury

  2011cited by this paper
• Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin‐induced type 1 diabetes

  2011influential reference
• Epoxyeicosatrienoic Acids Attenuate Reactive Oxygen Species Level, Mitochondrial Dysfunction, Caspase Activation, and Apoptosis in Carcinoma Cells Treated with Arsenic Trioxide

  2011cited by this paper
• The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension

  2010cited by this paper
• Targeting Epoxides for Organ Damage in Hypertension

  2010cited by this paper
• Development of Epoxyeicosatrienoic Acid Analogs with in Vivo Anti-Hypertensive Actions

  2010cited by this paper
• The use of capnometry to predict arterial partial pressure of CO2 in non-intubated breathless patients in the emergency department

  2010cited by this paper
• Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

  2009influential reference
• Peroxisome Proliferator-Activated Receptor γ Antagonists Decrease Na+ Transport via the Epithelial Na+ Channel

  2009cited by this paper
• Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

  2009cited by this paper
• Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.

  2009cited by this paper
• Soluble epoxide hydrolase, a target with multiple opportunities for cardiovascular drug discovery.

  2009cited by this paper
• 14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.

  2009cited by this paper
• Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.

  2008cited by this paper
• Pathogenesis of essential hypertension: historical paradigms and modern insights

  2008cited by this paper
• Cardiovascular Diabetology BioMed Central Hypothesis Important genetic checkpoints for insulin resistance in salt-sensitive

  2008cited by this paper
• Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.

  2008cited by this paper
• Cardiovascular Diabetology BioMed Central Commentary

  2008cited by this paper
• Pathophysiology of Salt-Sensitive Hypertension: A New Scope of an Old Problem

  2008cited by this paper
• Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury.

  2007cited by this paper
• Interactions between oxidative stress and inflammation in salt-sensitive hypertension.

  2007cited by this paper
• Acute regulation of the epithelial Na+ channel by phosphatidylinositide 3-OH kinase signaling in native collecting duct principal cells.

  2007cited by this paper
• Pathogenesis of salt sensitivity of blood pressure

  2006cited by this paper
• Immune Suppression Attenuates Hypertension and Renal Disease in the Dahl Salt-Sensitive Rat

  2006cited by this paper
• Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension

  2006cited by this paper
• Immune Suppression Prevents Renal Damage and Dysfunction and Reduces Arterial Pressure in Salt‐Sensitive Hypertension

  2006cited by this paper
• Antioxidant Treatment Prevents Renal Damage and Dysfunction and Reduces Arterial Pressure in Salt-Sensitive Hypertension

  2005cited by this paper
• Oxidative Stress and Antioxidant Treatment in Hypertension and the Associated Renal Damage

  2005cited by this paper
• Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles.

  2005cited by this paper
• An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension

  2005cited by this paper
• Arachidonic Acid Inhibits Epithelial Na Channel Via Cytochrome P450 (CYP) Epoxygenase-dependent Metabolic Pathways

  2004cited by this paper
• Sodium and blood pressure 2003

  2004cited by this paper
• Ras Activates the Epithelial Na+ Channel through Phosphoinositide 3-OH Kinase Signaling*

  2004cited by this paper
• Oxidative Stress in Dahl Salt‐Sensitive Hypertension

  2003cited by this paper
• Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase.

  2003cited by this paper
• 14,15-Epoxyeicosa-5(Z)-Enoic-mSI: A 14,15- and 5,6-EET Antagonist in Bovine Coronary Arteries

  2003cited by this paper
• Sodium and blood pressure

  2002cited by this paper
• 14,15-Epoxyeicosa-5(Z)-enoic Acid: A Selective Epoxyeicosatrienoic Acid Antagonist That Inhibits Endothelium-Dependent Hyperpolarization and Relaxation in Coronary Arteries

  2002cited by this paper
• A Mechanism of Oxygen Free Radical Production in the Dahl Hypertensive Rat

  1999cited by this paper
• Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy.

  1997cited by this paper
• Oxidative stress in the Dahl hypertensive rat.

  1997cited by this paper
• The role of the kidney in hypertension.

  1996cited by this paper
• Salt sensitivity in hypertension. Renal and cardiovascular implications.

  1994cited by this paper
• Salt Sensitivity in Hypertension

  year unknowncited by this paper

• Dynamics of Fatty Acid Composition in Lipids and Their Distinct Roles in Cardiometabolic Health

  2025cites this paper
• The Role of Arachidonic Acid Metabolizing Cytochromes P450 in the Control of Cardiovascular Functions

  2024cites this paper
• Research trends and hotpots on the relationship between high salt and hypertension: A bibliometric and visualized analysis

  2023cites this paper
• Novel Model of Oxalate Diet-Induced Chronic Kidney Disease in Dahl-Salt-Sensitive Rats

  2023cites this paper
• Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fraction.

  2022cites this paper
• Epoxyeicosatrienoic Acid administration or Soluble Epoxide Hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.

  2022cites this paper
• Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury.

  2022cites this paper
• Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney

  2021cites this paper
• Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats

  2021cites this paper
• Epoxylipids and Soluble Epoxide Hydrolase in Heart Diseases.

  2021cites this paper
• Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies

  2021cites this paper
• Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity

  2021cites this paper
• Recombinant Cellular Repressor of E1A-Stimulated Genes Protects against Renal Fibrosis in Dahl Salt-Sensitive Rats

  2020cites this paper
• Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics

  2020cites this paper
• Inflammatory macrophages in the kidney contribute to salt-sensitive hypertension.

  2020cites this paper
• Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice

  2019cites this paper
• Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension

  2019cites this paper
• Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats

  2019cites this paper
• Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats

  2019cites this paper
• Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice

  2019cites this paper
• Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor

  2019cites this paper
• Epoxyeicosanoids in hypertension.

  2019cites this paper
• Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics

  2018cites this paper
• Molecular Pathways in Hypertensive Renal Damage

  2018cites this paper
• Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.

  2018cites this paper
• Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases☆

  2017cites this paper
• Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition

  2017influential citation
• Soluble epoxide hydrolase as a therapeutic target for pain , in fl ammatory and neurodegenerative diseases ☆

  2017cites this paper
• Cordyceps militaris improves the survival of Dahl salt-sensitive hypertensive rats possibly via influences of mitochondria and autophagy functions

  2017cites this paper
• Cytochrome P450‐derived eicosanoids and heart function

  2017cites this paper
• Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases

  2017cites this paper
• Multiple Mechanisms are Involved in Salt-Sensitive Hypertension-Induced Renal Injury and Interstitial Fibrosis

  2017cites this paper
• Animal Models of Kidney Disease

  2017cites this paper
• Orally Active Epoxyeicosatrienoic Acid Analogs.

  2017cites this paper
• Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

  2017cites this paper
• Translational evaluation of cytochrome P450-derived epoxyeicosanoids in non-alcoholic steatohepatitis (NASH)

  2017cites this paper
• Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury

  2017cites this paper
• Involvement of ENaC in the development of salt-sensitive hypertension.

  2017cites this paper
• Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.

  2016cites this paper
• Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.

  2016cites this paper
• Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.

  2016cites this paper
• TRANSLATIONAL APPROACHES TO UNDERSTANDING THE ROLE OF CYTOCHROME P450-DERIVED EPOXYEICOSATRIENOIC ACIDS IN CORONARY ARTERY DISEASE

  2015cites this paper
• High Salt Intake Increases Blood Pressure in Normal Rats: Putative Role of 20-HETE and No Evidence on Changes in Renal Vascular Reactivity

  2015cites this paper
• Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.

  2015cites this paper
• In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.

  2015cites this paper
• Profibrotic Transcriptome Signature Macrophage Epoxygenase Determines a

  2015cites this paper
• Hydrogen Sulfide Inhibits High-Salt Diet-Induced Renal Oxidative Stress and Kidney Injury in Dahl Rats

  2015cites this paper
• Redox homeostasis, T cells and kidney diseases: three faces in the dark

  2015cites this paper
• Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway.

  2015cites this paper
• Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

  2015cites this paper
• Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.

  2015cites this paper
• Macrophage Epoxygenase Determines a Profibrotic Transcriptome Signature

  2015cites this paper
• Epoxyeicosatrienoic acids, hypertension, and kidney injury.

  2015cites this paper
• Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.

  2014cites this paper
• Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury

  2014cites this paper
• The Pharmacology of the Cytochrome P450 Epoxygenase/Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014cites this paper
• 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates: Carboxylate Modifications

  2014cites this paper
• PPARα activation can help prevent and treat non-small cell lung cancer.

  2014cites this paper
• PHARMREV007781 1106..1140

  2014influential citation
• Tumor and Stem Cell Biology PPAR a ActivationCanHelpPrevent andTreatNon – SmallCell Lung Cancer

  2014cites this paper
• Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury

  2014cites this paper
• Epoxyeicosatrienoic acids and cardioprotection: the road to translation.

  2014cites this paper
• The Pharmacology of the Cytochrome P 450 Epoxygenase / Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014influential citation
• Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.

  2014cites this paper
• renal disease

  year unknowncites this paper